Connor, Clark & Lunn Investment Management Ltd.

Position in RCUS — Arcus Biosciences, Inc.

CIK 1596800 VANCOUVER, A1

Position in RCUS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,936,996

+$852,687 QoQ

Shares Held

225,008

-20.1% QoQ

Ownership

0.177%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#48

of 230 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. RCUS ranks #23 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,936,996	225,008	-20.1%	Shares	Sole	2026-08-13
2026-03-31	$6,084,309	281,681	+38.6%	Shares	Sole	2026-05-11
2025-12-31	$4,843,876	203,268	+136.2%	Shares	Sole	2026-02-10
2025-09-30	$1,170,388	86,058	+34.4%	Shares	Sole	2025-11-13
2024-12-31	$953,600	64,043	-69.9%	Shares	Sole	2025-02-10
2022-03-31	$6,714,169	212,743	-20.2%	Shares	Sole	2022-05-12
2021-12-31	$10,786,995	266,543	-2.2%	Shares	Sole	2022-02-10
2021-09-30	$9,505,806	272,607	+1.4%	Shares	Sole	2021-11-12
2021-06-30	$7,378,804	268,711	+22.6%	Shares	Sole	2021-08-12
2021-03-31	$6,153,030	219,125	+12.6%	Shares	Sole	2021-05-13
2020-12-31	$5,050,232	194,539	+126.2%	Shares	Sole	2021-02-16
2020-09-30	$1,474,279	86,014	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.